Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

37.05 +0.64 (+1.76%)

Streaming Delayed Price Updated: 12:39 PM EST, Dec 24, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,315,491
Open	36.68
Bid (Size)	37.03 (200)
Ask (Size)	37.07 (300)
Prev. Close	36.41
Today's Range	36.22 - 37.83
52wk Range	18.92 - 43.55
Shares Outstanding	99,581,693
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Weight of Innovation: Eli Lilly’s Dominance in the GLP-1 Era

Today 10:01 EST

Date: December 24, 2025By: Financial Research Insights Introduction As 2025 draws to a close, few companies have dominated the financial and medical headlines as consistently as Eli Lilly and Company...

Via PredictStreet

Novo Nordisk Stock Soars as "Wegovy Pill" Gains FDA Approval, Reshaping Obesity Market

December 23, 2025

Shares of Novo Nordisk (NYSE: NVO) surged more than 8% in early trading on December 23, 2025, after the pharmaceutical giant secured a landmark FDA approval for its high-dose oral semaglutide, branded...

Via MarketMinute

Performance

YTD	-9.9%	-9.9%
1 Month	+7.0%	+7.0%
3 Month	+48.4%	+48.4%
6 Month	+37.5%	+37.5%
1 Year	-12.5%	-12.5%

More News

The Great Rotation: Small-Caps Break All-Time Highs as Investors Pivot from Mega-Tech

December 19, 2025

Via MarketMinute

The Great Rotation: Why the Russell 2000 is Finally Outpacing the Giants in Late 2025

December 18, 2025

Via MarketMinute

Eli Lilly’s Oral Obesity Drug Passes Maintenance Test After Wegovy, Zepbound — Wall Street Flags Win For Viking Therapeutics ↗

December 18, 2025

Via Stocktwits

2 Growth Stocks to Invest $1,000 in Right Now ↗

December 18, 2025

Via The Motley Fool

1 Bold Prediction for Viking Therapeutics in 2026 ↗

December 16, 2025

Via The Motley Fool

2 Monster Stocks in the Making to Buy and Hold ↗

December 16, 2025

Via The Motley Fool

My Top 10 Stocks to Buy for 2026 ↗

December 13, 2025

Via The Motley Fool

3 Underrated Growth Stocks That Look Like Great Buys Heading Into 2026 ↗

December 11, 2025

Via The Motley Fool

What's Up With The Jump In Viking Therapeutics Stock? ↗

December 04, 2025

Via Benzinga

Prediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029 ↗

November 27, 2025

Via The Motley Fool

Retail Traders Crown Novo Nordisk As Long-Term Weight Loss King — Even As Eli Lilly Hits $1T And Viking Fans Tout ‘M&A Prize’ ↗

November 25, 2025

Via Stocktwits

2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon ↗

November 22, 2025

Via The Motley Fool

3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential ↗

November 21, 2025

Via The Motley Fool

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗

November 19, 2025

Via The Motley Fool

5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity? ↗

November 18, 2025

Via The Motley Fool

2 No-Brainer Healthcare Stocks to Buy Now ↗

November 18, 2025

Via The Motley Fool

Druckenmiller Opens Position In Amazon, Closes Microsoft — Here's More Of Duquesne's Biggest Q3 Moves ↗

November 14, 2025

Via Benzinga

Viking Therapeutics Stock Soars To 10-Month High After Canaccord Boost – Retail Traders See It As Next Big Obesity Play ↗

November 13, 2025

Via Stocktwits

‘Somebody Knows Something:’ Viking Therapeutics Stock Pops To Nearly 3-Month High As Retail Traders Intensely Speculate On M&A Scenarios ↗

November 11, 2025

Via Stocktwits

AMD, Oklo, AppLovin Corp, Viking Therapeutics And Novo Nordisk: Why These 5 Stocks Are On Investors' Radars Today ↗

November 11, 2025

Via Benzinga

2 Monster Stocks in the Making ↗

November 10, 2025

Via The Motley Fool

Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith ↗

November 09, 2025

Via Stocktwits

Is There a Future for Viking Therapeutics? ↗

November 09, 2025

Via The Motley Fool

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?

Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Viking Therapeutics, Inc. - Common Stock trade on?

Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?

The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market

What is the current price of Viking Therapeutics, Inc. - Common Stock?

The current price of Viking Therapeutics, Inc. - Common Stock is 37.05

When was Viking Therapeutics, Inc. - Common Stock last traded?

The last trade of Viking Therapeutics, Inc. - Common Stock was at 12/24/25 12:39 PM ET

What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?

The market capitalization of Viking Therapeutics, Inc. - Common Stock is 3.69B

How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?

Viking Therapeutics, Inc. - Common Stock has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.